Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2020 American Society of Clinical Oncology
May 29, 2020 08:00 ET
|
ZIOPHARM Oncology Inc
– Longer term follow-up from Controlled IL-12 monotherapy studies reinforces encouraging median overall survival and favorable safety profile – – Controlled IL-12 in combination with PD-1...
Candente Gold Advances new Growth Strategy
May 29, 2020 08:00 ET
|
Candente Gold Corp.
VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) -- Candente Gold Corp. (TSXV:CDG) ("Candente Gold” and/or the “Company”) is pleased to advise that the Company is continuing to use the...
Verizon to redeem debt securities on June 29, 2020
May 29, 2020 08:00 ET
|
Verizon Communications
NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, NASDAQ: VZ) today announced that it will redeem the following notes on June 29, 2020 (the “Redemption...
Allogene Therapeutics, with Collaborator Servier, Reports Positive Results from its Phase 1 ALPHA Study of ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology Annual Meeting
May 29, 2020 08:00 ET
|
Allogene Therapeutics, Inc.
ALLO-501 with ALLO-647 Lymphodepletion was Well Tolerated with No Dose-Limiting Toxicities, Graft-vs-Host Disease or Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)In the Ongoing Study,...
Defense Innovation Unit Selects Zscaler for Secure Cloud Management Project
May 29, 2020 08:00 ET
|
Zscaler, Inc.
SAN JOSE, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that the Defense Innovation Unit (DIU), a U.S. Department of Defense...
Athenex 在 ASCO20 虛擬科學計劃中展示在皮膚紫杉醇肉瘤使用口服紫杉醇第二期研究的中期數據
May 29, 2020 08:00 ET
|
Athenex, Inc.
紐約水牛城, May 29, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX) 作為全球致力於研究、開發和商業化用於治療癌症新療法的生物製藥公司，今天展示正在進行的一項第二期臨床試驗的臨時數據，顯示口服紫杉醇和 encequidar（「口服紫杉醇」，前稱...
HEALTH ORGANIZATIONS CHALLENGE JUUL AND RONA AMBROSE TO BAN FLAVOURS AND REDUCE NICOTINE CONTENT IN ALL OF ITS VAPING PRODUCTS
May 29, 2020 08:00 ET
|
ASH Canada
Canada, May 29, 2020 (GLOBE NEWSWIRE) -- Ottawa, Toronto, Montreal, Edmonton - Nicotine giant Juul and its latest board member—former Canadian Health Minister Rona Ambrose—are being challenged to...
Syapse Announces Research Using Real-World Evidence at ASCO20 Virtual
May 29, 2020 08:00 ET
|
Syapse
SAN FRANCISCO, May 29, 2020 (GLOBE NEWSWIRE) -- Syapse today announced multiple research abstracts based on real-world data at the ASCO20 Virtual Annual Meeting. Syapse pairs holistic clinical...
Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time
May 29, 2020 08:00 ET
|
Sanofi
Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time *Across all groups combined, complete...
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
May 29, 2020 08:00 ET
|
Larimar Therapeutics, Inc.
- Shares of combined company to commence trading on Nasdaq Global Market under the symbol “LRMR” on May 29, 2020- Company signed $80 million in private placement financing with biotechnology focused...
- May 11, 2024 11:17 ET KFSH&RC 三大卓越中心在医学界取得骄人突破成就
- May 11, 2024 06:01 ET KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value